HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 7 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,241,631 | +40.3% | 3,867,000 | 0.0% | 0.10% | +63.8% |
| Q3 2022 | $6,587,000 | -12.5% | 3,867,000 | -3.3% | 0.06% | +1.8% |
| Q2 2022 | $7,530,000 | +8.6% | 4,000,000 | 0.0% | 0.06% | -39.4% |
| Q1 2022 | $6,931,000 | +12.9% | 4,000,000 | +14.3% | 0.09% | +51.6% |
| Q4 2021 | $6,138,000 | +72.3% | 3,500,000 | +75.0% | 0.06% | +29.2% |
| Q3 2021 | $3,562,000 | – | 2,000,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |